GlaxoSmithKline (JOBS) Eyes up Human Genome Sciences, Inc.
NEW YORK (Reuters) - Human Genome Sciences Inc (HGSI.O) shares rose nearly 12 percent on Tuesday on renewed chatter that GlaxoSmithKline Plc (GSK.L) was set to pay a healthy premium for the company to gain full control of the promising lupus drug Benlysta.